Sotigalimab Uses, Dosage, Side Effects and more
Sotigalimab is under investigation in clinical trial NCT03123783 (CD40 Agonistic Antibody APX005M in Combination With Nivolumab).
Trade Name | Sotigalimab |
Generic | Sotigalimab |
Sotigalimab Other Names | Sotigalimab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |